Global Image-Guided Treatment System Market : Research Consumption, Companies , Industry Report Analysis and Future Demand

SDKI Inc. published a new report on "Global Image Guided Therapy System Market-Forecast 2022-2030". This study includes the statistical and analytical approaches needed to grow the image-guided therapy system market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111625

The image-guided therapy system market is estimated to reach US $ 3.55 billion by 2030 from a market value of US $ 2.36 billion in 2022 and is expected to grow at a CAGR of 6.0% during the 2022-2030 forecast period. increase.

The image-guided therapy system is by navigating the device inside the patient's body. Assist the surgeon to display a 3D image of the target area. Image-guided treatment systems are always informative, allowing surgeons to plan surgery, make adjustments in a very short amount of time, and make surgery safer and less invasive. It is useful in treating various therapeutic areas such as pain, trauma, urology, heart, blood vessels, intravascular, spine, orthopedics, and neurology. It is also used to treat hypertension with renal denervation.

Increasing technological advances, an increasing aging population, and an increasing prevalence of chronic diseases are key factors driving the growth of the image-guided therapy system market during the forecast period. According to the American Hospital Association, the number of Americans with chronic illnesses was 149 million in 2015, and it is estimated that 164 million Americans will suffer from chronic illnesses by 2025. Similarly, according to the International Respiratory Society (FIRS) forum, about 384 million people suffer from chronic obstructive pulmonary disease (COPD), and 3 million die from it each year. Therefore, it is the third leading cause of death in the world.

However, the high price of image-guided therapy systems could curb the growth of the global image-guided therapy system market during the forecast period.

Sample URL for the report
https://www.sdki.jp/sample-request-111625

Global market growth can be attributed to various significant advances in the healthcare industry to promote health through the development of three basic parameters: detection, prevention, and treatment. These parameters are needed to measure health, quality of life, and the overall health system. In addition, rising medical costs are driving market growth. According to the Organization for Economic Co-operation and Development (OECD) statistics, Japan's total per capita health care costs (government, compulsory health insurance, voluntary health insurance) increased from US $ 4297.13 in 2016 to US $ 4823 in 2019. Similarly, in the United States, it increased from $ 9880.16 to $ 11072 in 2019. Germany has witnessed an increase from $ 5668 to $ 6646, and the United Kingdom has observed growth from $ 3990 to $ 4653.05 during the above period. Globally, healthcare costs are projected to grow at a CAGR of approximately 5% between 2020 and 2024.

Advances in the healthcare sector are estimated to provide lucrative business opportunities for key players to take advantage of these opportunities in the coming years. In addition, there are several initiatives taken by healthcare professionals and government agencies to overcome some challenges (unreachable and affordable medical services, lack of investment in health care, trained doctors and nurses, etc.). It is expected to boost market growth during the forecast period.

Image-guided therapy system market segment

The image-guided treatment system market is by product (ultrasonic system, computer tomography (CT) scanner, positron emission tomography (PET), endoscope, magnetic resonance imaging (MRI), X-ray fluoroscopy and single photon emission. Radiation Computer Tomography (SPECT)), Application (Cardiac Surgery, Neurosurgery, Orthopedic, Urology, Tumor Surgery, Gastrointestinal Diseases and Others), End Use (Hospital, Specialty Clinic, Outpatient Surgery Center, and Research)・ Academic institutions) and regions. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

image-guided therapy system market The image-guided therapy system market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

The North American region is a major region of the world during the forecast period. This is due to improved medical infrastructure, technological advances, and the rapid adoption of advanced radiation therapy in the region. Meanwhile, the Asia Pacific image-guided therapy system market is also expected to show the highest growth rate / CAGR during the 2022-2030 forecast period. In addition, Indian private healthcare institutions have established world-class capabilities, which will drive the demand for image-guided therapy systems.

Leading key player in the image-guided therapy system market

Key players in the image-guided therapy system market include Koninklijke Philips NV, Medtronic Plc, Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems, Inc., Brainlab AG, Olympus Corporation and Stryker Corporation. The study includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these leading companies in the image-guided therapy system market.

Details of the survey report
https://www.sdki.jp/press-details/global-image-guided-therapy-system-market/327

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.